Tag: Federal Trade Commission

FTC settles false advertising suit against low-level light therapy marketer with $22 million judgment

Per a settlement with the FTC, the marketers of Willow Curve, a low-level light therapy device costing hundreds of dollars, will have to stop making deceptive claims that the device treats chronic, severe pain and associated inflammation. Any health claims made for the device must be supported by "competent and reliable scientific evidence".

/ July 2, 2020

FTC warns naturopaths, acupuncturists, physicians, and chiropractors about false and misleading COVID-19 claims  

Since March, the FTC has issued almost 250 warning letters to companies and individuals making unsubstantiated claims for COVID-19 treatments. Included among these are naturopaths, acupuncturists, physicians, and chiropractors.

/ June 18, 2020

Dubious for-profit stem cell clinics: Co-opting ClinicalTrials.gov as a marketing tool

Over twenty years ago, cancer quack Stanislaw Burzynski pioneered the abuse of the clinical trial process as a marketing tool to sell his antineoplastons. Now, for-profit stem cell clinics are using ClinicalTrials.gov as a marketing tool for their unproven therapies by listing dubious and scientifically worthless trials in this government database. What can be done?

/ June 17, 2019

Walmart sued for deceiving customers in selling homeopathic remedies

A lawsuit claiming Walmart fraudulently deceives consumers in the sale of worthless homeopathic remedies has been filed by the Center for Inquiry (CFI), acting on behalf of the general public. CFI says co-mingling ineffective homeopathic products with science-based treatments on Walmart's pharmacy shelves and website misleads customers into thinking they are equivalent, when "there is not a shred of credible scientific evidence"...

/ June 6, 2019

The stem cell hard sell: The Medical Board of California is forming a task force to determine how to regulate physicians offering stem cell therapies.

For-profit stem cell clinics selling unproven and downright quacky stem cell therapies have proliferated over the last several years, with federal and state law seemingly powerless to stop them. Recently, the FDA and FTC have shown signs of acting to crack down on them. Now, the Medical Board of California is forming a task force to determine how to regulate physicians offering...

/ December 10, 2018

FTC settles deceptive advertising claims against amniotic stem cell clinics

An FTC settlement may kill "amniotic stem cell" treatments, but a plethora of other stem cell clinics flourish without regulatory oversight.

/ October 25, 2018
iV Bars

The FTC cracks down on iV Bars for false advertising claims about its “intravenous micronutrient therapy”

One of the most popular forms of quackery sold by alternative medicine practitioners such as naturopaths is intravenous vitamin therapy, sometimes also called "intravenous micronutrient therapy" (IVMT). Most are variants of a concoction known as "Myers cocktail," and there is no good evidence that IVMT is efficacious for any of the indications for which quacks use it. Last week, the FTC issued...

/ September 24, 2018

Prevagen goes P-hacking

Can post-hoc data-dredging produce competent and reliable scientific evidence for Prevagen's claims of memory improvement? The FTC and consumer groups say "no."

/ June 21, 2018

CVS selling homeopathic remedies: It gets personal

I almost purchased a worthless homeopathic eye remedy at CVS for a cancer patient. I'm taking action to try to stop this from happening to others.

/ March 30, 2017

Regulating Health Care Products

How should we optimally regulate health care products to protect consumers? A conversation with the Acting Chairman of the FTC.

/ February 15, 2017